Inhalation of specific anti-Pseudomonas aeruginosa IgY antibodies transiently decreases P. aeruginosa colonization of the airway in mechanically ventilated piglets

[1]  K. Asehnoune,et al.  Safety and tolerability of a single administration of AR-301, a human monoclonal antibody, in ICU patients with severe pneumonia caused by Staphylococcus aureus: first-in-human trial , 2018, Intensive Care Medicine.

[2]  Mohamed E A Abdelrahim,et al.  Inhaled salbutamol dose delivered by jet nebulizer, vibrating mesh nebulizer and metered dose inhaler with spacer during invasive mechanical ventilation. , 2017, Pulmonary pharmacology & therapeutics.

[3]  Yang Wang,et al.  Comparative Study on the Size Distributions, Respiratory Deposition, and Transport of Particles Generated from Commonly Used Medical Nebulizers. , 2017, Journal of aerosol medicine and pulmonary drug delivery.

[4]  B. Rehm,et al.  Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence , 2017, Front. Cell. Infect. Microbiol..

[5]  Yu Cao,et al.  Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis. , 2016, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[6]  N. Høiby,et al.  Anti-Pseudomonas aeruginosa IgY antibodies promote bacterial opsonization and augment the phagocytic activity of polymorphonuclear neutrophils , 2016, Human vaccines & immunotherapeutics.

[7]  C. Schultsz,et al.  Development of Antibiotic Resistance during Simulated Treatment of Pseudomonas aeruginosa in Chemostats , 2016, PloS one.

[8]  N. Høiby,et al.  Anti-Pseudomonas aeruginosa IgY antibodies augment bacterial clearance in a murine pneumonia model. , 2014, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[9]  R. Kallet.  The Vexing Problem of Ventilator-Associated Pneumonia: Observations on Pathophysiology, Public Policy, and Clinical Science , 2015, Respiratory Care.

[10]  J. Vila,et al.  A Novel Porcine Model of Ventilator-associated Pneumonia Caused by Oropharyngeal Challenge with Pseudomonas aeruginosa , 2014, Anesthesiology.

[11]  R. Pinciroli,et al.  Ventilator Associated Pneumonia: Evolving Definitions and Preventive Strategies , 2013, Respiratory Care.

[12]  B. Brembs,et al.  IgY Technology: Extraction of Chicken Antibodies from Egg Yolk by Polyethylene Glycol (PEG) Precipitation , 2011, Journal of visualized experiments : JoVE.

[13]  J. Weingarten,et al.  Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source. , 2011, Chest.

[14]  D. Tambourgi,et al.  IgY: A promising antibody for use in immunodiagnostic and in immunotherapy , 2010, Veterinary Immunology and Immunopathology.

[15]  A. Larsson,et al.  Good effect of IgY against Pseudomonas aeruginosa infections in cystic fibrosis patients , 2008, Pediatric pulmonology.

[16]  R. Flavell,et al.  Involvement of Toll-like receptor 5 in the recognition of flagellated bacteria , 2006, Proceedings of the National Academy of Sciences.

[17]  C. Sprung,et al.  Sepsis in European intensive care units: Results of the SOAP study* , 2006, Critical care medicine.

[18]  S. McSorley,et al.  Salmonella flagellin, a microbial target of the innate and adaptive immune system. , 2005, Immunology letters.

[19]  D. Carlander,et al.  Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with cystic fibrosis: A phase I feasibility study , 2003, Pediatric pulmonology.

[20]  R. C. Peralta,et al.  Detection of passage and absorption of chicken egg yolk immunoglobulins in the gastrointestinal tract of pigs by use of enzyme-linked immunosorbent assay and fluorescent antibody testing. , 1993, American journal of veterinary research.

[21]  M. V. Van Regenmortel,et al.  Isolation of viral IgY antibodies from yolks of immunized hens. , 1980, Immunological communications.